Guided Therapeutics’ to Sell Five Additional LuViva® Advanced Cervical Scans to Kenya for Cervical Cancer Screening Program

Guided Therapeutics, Inc. (OTCQB:GTHP) announced that Nairobi County Health Services Sector has agreed to purchase an additional five LuViva® Advanced Cervical Scans for use in the agency’s cervical cancer screening program.

According to the company’s press release:
The five LuVivas are expected to ship in Q1 2016. The planned purchase brings to six the number of LuVivas purchased by Nairobi County with an additional seven units planned for purchase in 2016. When fully implemented, the County will have the capacity to screen more than 12,000 women per month.

Gene Cartwright, CEO and President of Guided Therapeutics commented:

We believe that working with governments is the most effective way to use LuViva for the early detection of cervical cancer and we are pleased to be working with Nairobi County. Management is proud to be on the front line, helping to address such a serious issue. LuViva is part of government programs now in Kenya and in Asia and we continue to work with governments in Asia and Latin America to expand its use as a front line tool for cervical cancer screening.

Click here to view the full press release.